This is supported by our findings that therapeutic administration of agents that induce M2 macrophages (e.g., rosiglitazone (RGZ), a PPARγ agonist, IL-4/anti-IL-4 complexes, and azithromycin) enhanced resolution of RSV-induced ALI in mice (23). The gene discussed is PPARG; the disease is acute respiratory distress syndrome.